MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GOSS — Gossamer Bio, Inc. Common Stock
NasdaqGossamer Bio, Inc. Common Stock
$10.71
-0.22(-2.01%)
- O
- 11.19
- H
- 11.19
- L
- 10.19
- V
- 234.19K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About GOSS
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateFeb 8, 2019
Employees162
Stock ExchangeNasdaq
Ticker SymbolGOSS
Websitehttps://www.gossamerbio.com
Key Financial Statistics
| Market Cap | $65.51M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.11 - $14.75 |
| 52-Week Avg Volume | 13.08M |
| VWAP | $10.72 |
| Transactions | 3,467 |
| Total Recorded Bars | 1,923 days |